ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
15 hedge funds and large institutions have $181K invested in Avenue Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$34K | |
| 2 | +$10K | |
| 3 | +$7K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$5.31K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$3K |
Top Sellers
| 1 | -$87.7K | |
| 2 | -$57K | |
| 3 | -$28K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.67K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$7.3K |